Acute Kidney Injury in Patients Hospitalized With COVID-19 in Wuhan, China: a Single-center Retrospective Observational Study

Zhenhua Zen1 site in 1 country287 target enrollmentFebruary 26, 2020

ConditionsCOVID-19 Acute Kidney Injury Kidney Function

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: COVID-19
Sponsor: Zhenhua Zen
Enrollment: 287
Locations: 1
Primary Endpoint: Rate of Acute Kidney Injury
Status: Completed
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The kidney may be affected in coronavirus-2019 disease (COVID-19). This study assessed the predictors and outcomes of acute kidney injury (AKI) among individuals with COVID-19.

Registry

clinicaltrials.gov

Start Date

February 26, 2020

End Date

March 8, 2020

Last Updated

6 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Zhenhua Zen

Responsible Party

Sponsor Investigator

Principal Investigator

Zhenhua Zen

Associate Professor

Nanfang Hospital, Southern Medical University

Eligibility Criteria

Inclusion Criteria

•COVID-19 pneumonia patients diagnosed by WHO criteria

Exclusion Criteria

•Patients who were younger than 18 years,
•Patients who had undergone renal replacement therapy (RRT) before admission,
•Patients whose entire stay lasted for less than 48 hours.

Outcomes

Primary Outcomes

Rate of Acute Kidney Injury

Time Frame: From date of admission until the date of discharge or death from any cause, up to 60 days

the incidence of Acute Kidney Injury

Secondary Outcomes

Rate of Death(From date of admission until the date of death from any cause, up to 60 days)
the length of hospital stay(From date of admission until the date of discharge or death from any cause, up to 60 days)